Testing
http://goo.gl/p6a15d
https://docs.google.com/presentation/d/1ElI6rxLsq1SAlB69bsvti1_sK6A7W7pXP6Zmn7WM_lc/pub?start=false&loop=false&delayms=3000 Continue Reading
Author: James Love
Lunch with the ACTA negotiators, August 17, 2010
On Tuesday, August 17, 2010, USTR organized a lunch between ACTA negotiators and civil society NGOs. There was not much notice. We received our invite to the lunch last Thursday. Representatives from KEI, Public Citizen, Oxfam, Public Knowledge and the American University program on intellectual property attended the event.
The US Orphan Drug Tax Credit
From the FDA page on the Orphan Drug Tax Credit. Incentives TAX CREDIT (See Footnote 1 below) FOR TESTING EXPENSES FOR DRUGS FOR RARE DISEASES OR CONDITIONS Introduction Section 45C of the Internal Revenue Code of 1954 allows a credit… Continue Reading
Notes and data points for prices of orphan products
February 22, 2010., Matthew Herper, “The World’s Most Expensive Drugs,” Forbes. Genzyme’s web page on the cost of treatment. Some data points on Fabrazyme prices. 2004 prices for Replagal 2001 prices for Cerezyme. Myozyme/Lumizyme A 2007 Canadian analysis of (50… Continue Reading
Written submission U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Hearing on Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures
Written submission U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Hearing on Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures, On the topic of Direct funding, subsidies and incentives for the development… Continue Reading
Luc Devigne’s role in ACTA negotiations
On Saturday, July 17, 2010, I said on twitter, “Apparently Luc Devigne is out as head #acta negotiator for EU.” There were a number of sources for this inside the European Union and also among other trade bodies or governments following or participating in the ACTA negotiations.
This was re-tweeted extensively, and resulted in various commentary and reporting on LucDevigne’s rule in ACTA, including speculation on the reasons for the change.
ACTA’s Article 2.3, on “Other Remedies”: the July 1, 2010 text
Article 2.3 of the July 1, 2010 version of the ACTA text provides for “Other Remedies” for infringement. The Japan, Switzerland and EU versions of the text appear to be overreaching, including for example by directly conflicting with explicit TRIPS provisions and provisions in the laws of ACTA negotiating countries, including several European Countries.
ACTA’s Article 2.2.1, on damages:the July 1, 2010 text
The July 1, 2010 ACTA text includes several provisions that would set global norms for damages, including most importantly, on pages 6 and 7, Article 2.2 on Damages. Also relevant are the provisions in Article 2.X on General Obligations with Respect to Enforcement, on page 5.
ACTA’s Article 2.X on Injunctions: the July 1, 2010 text
From the July 1, 2010 text of ACTA:
Article 2.X InjunctionsThe July 23, 1990 Draft WTO text on TRADE IN COUNTERFEIT AND PIRATED GOODS
The July 23, 1990 draft of the TRIPS Agreement contained the following proposal to deal with trade in counterfeit and pirated goods.
PART IX: TRADE IN COUNTERFEIT AND PIRATED GOODS1. Preamble
MTN.GNG/NG11/W/76
Page 331B.1 Desirous of providing for adequate procedures and remedies to discourage international trade in counterfeit and
pirated goods while ensuring an unimpeded flow of trade in legitimate goods;